Key facts
- It has raised $22.0M; the latest was Later Stage VC in Jul 2024.
- Notable investors include Michigan State University, PV Capital Management, BioInc@NYMC, Fresenius Medical Care Ventures, Red Cedar Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Retia Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Retia Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Retia Medical
Developer of a medical device designed to improve patient care by providing accurate data on blood flow. The company offers a monitoring device that uses a special algorithm to measure blood flow and helps to make informed decisions, enabling doctors to improve patient care in critical conditions like sepsis and transplants.
- Sector
- Healthcare
- HQ
- White Plains, NY, United States
- Founded
- 2011
- Employees
- 16
- Website
- retiamedical.com/
- Ownership
- Privately Held (backing)
Retia Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Retia Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Retia Medical in its N-PORT filings yet. We sweep new filings monthly.